Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Therapeutic Context Research findings suggest that the optimal use of BPC-157 is in many cases dependent on the therapeutic target, as different routes of delivery and dosages elicit varying effects
In laboratory and animal studies, GHK-Cu is reported to stimulate collagen and elastin synthesis , support wound healing and angiogenesis , act as an antioxidant and anti-inflammatory , and modulate the expression of genes tied to skin repair and tissue remodeling [3] [4] [5]
2Inject the water slowly down the inside wall of the peptide vial, avoiding foaming or vigorous agitation
This multi-receptor activation enables: GLP-1R activation enhances glucose-dependent insulin secretion and reduces appetite through hypothalamic signaling GIPR activation (highest potency: EC50 0.0643 nM) promotes insulin secretion and modulates lipid metabolism GCGR activation (EC50 5.79 nM) increases energy expenditure and promotes hepatic fat oxidation Combined receptor engagement produces dose-dependent reductions in body weight and improvements in glycemic control Research demonstrates that GLP3s balanced activation across three receptors produces superior metabolic effects compared to single or dual agonists, with phase 2 trials showing up to 24.2% weight reduction in 48 weeks[2]
